Enoxaparin

tissue factor pathway inhibitor ; Homo sapiens







19 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30198315 Comparative Pharmacokinetic Profile of 3 Batches of Ovine Low-Molecular-Weight Heparin and 1 Batch of Branded Enoxaparin. 2018 Dec 1
2 26377606 The Levels of Tissue Factor Pathway Inhibitor in Sepsis Patients Receiving Prophylactic Enoxaparin. 2016 Jun 5 2
3 25525049 Evaluation of Immunostimulatory Potential of Branded and US-Generic Enoxaparins in an In Vitro Human Immune System Model. 2015 Apr 6
4 25278813 Successful thrombolysis following enoxaparin therapy in two pediatric patients with congenital heart disease presenting with intracardiac and cerebral thrombosis. 2014 1
5 20682597 Different effects of enoxaparin, nadroparin, and dalteparin on plasma TFPI during hemodialysis: a prospective crossover randomized study. 2011 Oct 2
6 19954711 Comparative pharmacodynamic time-course of bemiparin and enoxaparin in healthy volunteers. 2009 Dec 1
7 16194212 Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatment. 2005 Oct 1
8 15467899 Total tissue factor pathway inhibitor is an independent risk factor for symptomatic paediatric venous thromboembolism and stroke. 2004 Oct 1
9 15815881 Vascular endothelial tissue factor pathway inhibitor kinetics in culture following exposure to DX-9065a--a selective and direct factor Xa inhibitor. 2004 Dec 1
10 12801846 Effect of unfractionated heparin and a low molecular weight heparin (enoxaparin) on coagulant activity of cultured human endothelial cells. 2003 Jun 1
11 12808176 Different effects of enoxaparin and unfractionated heparin on extrinsic blood coagulation during haemodialysis: a prospective study. 2003 Jul 1
12 11190908 Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgery. 2001 Jan 1
13 11372675 Plasma levels of total and free tissue factor pathway inhibitor (TFPI) as individual pharmacological parameters of various heparins. 2001 May 1
14 11454528 Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes. 2001 Jul 1
15 11460016 Polymorphisms of the tissue factor pathway inhibitor gene and the risk of restenosis after coronary angioplasty. 2001 Jun 1
16 10847421 Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins. 2000 Jun 1
17 11030526 Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgery. 2000 Oct 1
18 9674734 Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action. 1998 Jun 1
19 7605876 Effect of repeated Aprosulate and Enoxaparin administration on tissue factor pathway inhibitor antigen levels. 1995 Apr 1